Revised Prices of Anti-Cancer Medicines to Come into Effect from 9th November;

The NPPA capped trade margins on 137 anti-cancer drugs, with revised prices effective from 9th November 2026, leading to an estimated annual consumer saving of ₹3,502.31 crore.

• The Expert Committee constituted by DGHS under Ministry of Health & Family Welfare made recommendations on 17th October, 2026.
• 76 pharmaceutical companies reported revised MRP for 1225 anti-cancer formulations covering 121 drugs.
• 1031 formulations saw a reduction, with 600 brands reporting above 50% reduction and the highest reduction being 96.45%.
• Trade Margin Rationalization will apply to 10-15 drugs not yet launched in India.
• Retailers must display revised MRP lists on their websites and premises.
• Consumers can report non-compliance via the Pharma Sahi Daam app, email, helpline 1800-11-1255, or post to the NPPA office.